PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.66%
Negative revenue growth while 3391.T stands at 0.53%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.38%
Negative gross profit growth while 3391.T is at 1.16%. Joel Greenblatt would examine cost competitiveness or demand decline.
-15.27%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-23.77%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-15.66%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-15.66%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-15.66%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
74.19%
10Y CAGR of 74.19% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
66.93%
5Y revenue/share CAGR at 50-75% of 3391.T's 109.82%. Martin Whitman would worry about a lagging mid-term growth trajectory.
36.33%
3Y revenue/share CAGR at 50-75% of 3391.T's 58.75%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
197.70%
10Y net income/share CAGR of 197.70% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
61.57%
5Y net income/share CAGR similar to 3391.T's 62.84%. Walter Schloss might see both on parallel mid-term trajectories.
48.90%
3Y net income/share CAGR 1.25-1.5x 3391.T's 36.00%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
222.31%
Equity/share CAGR of 222.31% while 3391.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
133.90%
5Y equity/share CAGR above 1.5x 3391.T's 79.88%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
65.83%
3Y equity/share CAGR above 1.5x 3391.T's 36.58%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-10.00%
Negative 5Y dividend/share CAGR while 3391.T stands at 124.62%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
50.00%
3Y dividend/share CAGR at 75-90% of 3391.T's 65.91%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
147.76%
AR growth well above 3391.T's 5.85%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.38%
Inventory growth well above 3391.T's 4.10%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.02%
Asset growth at 50-75% of 3391.T's 1.76%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
3.65%
1.25-1.5x 3391.T's 2.67%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-7.61%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
1.36%
SG&A declining or stable vs. 3391.T's 6.18%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.